[HTML][HTML] Molecular mechanisms of ferroptosis and its role in prostate cancer therapy
S Wang, W Wei, N Ma, Y Qu, Q Liu - Critical reviews in oncology …, 2022 - Elsevier
Prostate cancer (PCa) is a highly prevalent disease that affects men's health worldwide and
is the second most common malignancy in males. Ferroptosis is a novel form of …
is the second most common malignancy in males. Ferroptosis is a novel form of …
Immunotherapy for bladder cancer: latest advances and ongoing clinical trials
DF Ward Grados, H Ahmadi, TS Griffith… - Immunological …, 2022 - Taylor & Francis
For nearly 50 years, immunotherapy has been used in patients with bladder cancer in the
form of Mycobacterium bovis Bacillus Calmette-Guerin (BCG), which is still the first-line …
form of Mycobacterium bovis Bacillus Calmette-Guerin (BCG), which is still the first-line …
Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
J Liu, R Geng, S Ni, L Cai, S Yang, F Shao… - … Therapy-Nucleic Acids, 2022 - cell.com
Uterine corpus endometrial carcinoma (UCEC) is a malignant disease globally, and there is
no unified prognostic signature at present. In our study, two clusters were identified. Cluster …
no unified prognostic signature at present. In our study, two clusters were identified. Cluster …
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
C Martins-Lima, U Chianese, R Benedetti… - Frontiers in molecular …, 2023 - frontiersin.org
Bladder cancer (BlCa) is a highly immunogenic cancer. Bacillus Calmette-Guérin (BCG) is
the standard treatment for non-muscle invasive bladder cancer (NMIBC) patients and …
the standard treatment for non-muscle invasive bladder cancer (NMIBC) patients and …
The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer
F Long, W Wang, S Li, B Wang, X Hu, J Wang… - Journal of translational …, 2023 - Springer
Background Although immunotherapy is effective in improving the clinical outcomes of
patients with bladder cancer (BC), it is only effective in a small percentage of patients …
patients with bladder cancer (BC), it is only effective in a small percentage of patients …
125I粒子植入放疗对前列腺癌免疫微环境影响的初步分析
王增增, 徐勇 - 临床泌尿外科杂志, 2022 - lcmw.whuhzzs.com
目的探讨125 I 粒子植入放疗对前列腺癌免疫微环境的影响. 方法利用免疫组织化学技术检测,
比较cT 1~ 3 N 0 M 0 期前列腺癌行125 I 粒子植入治疗前, 后前列腺癌细胞PD-L1 表达情况 …
比较cT 1~ 3 N 0 M 0 期前列腺癌行125 I 粒子植入治疗前, 后前列腺癌细胞PD-L1 表达情况 …
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
The stromal component of the tumour microenvironment in primary and metastatic prostate
cancer can influence and promote disease progression. Within the prostatic stroma …
cancer can influence and promote disease progression. Within the prostatic stroma …
RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy
Z Han, X Yi, J Li, T Zhang, D Liao, J You, J Ai - Biochimica et Biophysica …, 2023 - Elsevier
Prostate cancer (PCa) is the most common malignant tumor and the second leading cause
of cancer-related mortality in men worldwide. Despite significant advances in PCa therapy …
of cancer-related mortality in men worldwide. Despite significant advances in PCa therapy …
Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma
J Zheng, L Peng, S Zhang, H Liao, J Hao… - Frontiers in …, 2023 - frontiersin.org
Background The systemic immune-inflammation index (SII) is a cost-efficient indicator for
carcinoma prognosis. However, its utility in urothelial carcinoma (UC) prognosis is disputed …
carcinoma prognosis. However, its utility in urothelial carcinoma (UC) prognosis is disputed …
Genitourinary cancer neoadjuvant therapies: current and future approaches
SS Nair, D Chakravarty, V Patel, N Bhardwaj… - Trends in Cancer, 2023 - cell.com
Neoadjuvant therapies can improve tolerability, reduce tumor volume to facilitate surgery,
and assess subsequent treatment response. Therefore, there is much enthusiasm for …
and assess subsequent treatment response. Therefore, there is much enthusiasm for …